Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)

Belfast Health and Social Care Trust

This public procurement record has 3 releases in its history.

Award

29 Sep 2026 at 11:56

UK7 - Contract Details Notice
Award

08 Sep 2026 at 10:22

UK6 - Contract Award Notice
Award

07 Sep 2026 at 13:21

UK5 - Transparency Notice
Summary of the contracting process

Belfast Health & Social Care Trust procured agalsidase alfa 3.5 mg/3.5 mL concentrate for solution for infusion, supplied as a 3.5 mL vial in a pack of one, for homecare. This is a specialist pharmaceutical product used in patient treatment, with homecare support forming part of the stated requirement. The buyer is Belfast Health & Social Care Trust, and delivery is in the United Kingdom. The purchase is for the medicine itself rather than a general pharmacy or healthcare service.

The procurement is complete and the contract has been awarded to Sciensus Pharma Services Limited. The Trust used a direct award, citing the need to secure these essential medicines from this supplier to maintain continuity of patient care, specifically homecare support. The stated rationale says the absence of competition does not artificially narrow the procurement. The award date was 8 September 2026; the contract was signed on 29 September 2026. Its value is £670,000, and its period runs from 29 September 2026 to 30 September 2028. There is one lot, covering the agalsidase alfa medicine. The award identifies the product and supplier; no separate evaluation criteria are set out.

For pharmaceutical suppliers, the contract demonstrates demand from Belfast Health & Social Care Trust for agalsidase alfa supplied in a specific infusion concentrate strength and vial pack, with homecare support central to continuity of patient treatment. A credible future competitor would need to supply this specialist medicine reliably and show that its arrangements can sustain uninterrupted patient care through the homecare route. The direct award rationale makes continuity with the named supplier a material feature of this purchase, rather than a contest based on stated scored criteria. Suppliers with relevant pharmaceutical supply capability and the operational capacity to support dependable homecare delivery are best aligned with this requirement when it returns to market.

How relevant is this notice?

Notice Information

Notice Title

AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)

Notice Description

PROCUREMENT OF AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)

Procurement Information

These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06f379
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/091789-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£670,000 £500K-£1M
Contracts Value
£670,000 £500K-£1M

Notice Dates

Publication Date
29 Sep 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
8 Sep 20261 months ago
Contract Period
29 Sep 2026 - 30 Sep 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Belfast Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BELFAST
Postcode
BT12 6BA
Postcode Area
Northern Ireland
Country
Northern Ireland
Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN06 Belfast
Delivery Location
Not specified
Local Authority
Belfast
Electoral Ward
Falls
Westminster Constituency
Belfast West

Supplier Information

Number of Suppliers
1
Supplier Name

SCIENSUS PHARMA SERVICES LIMITED

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...